Pascal Biosciences announced optimization of cannabinoid-derived drug candidates to kill glioblastoma cells
On Nov. 5, 2018, Pascal Biosciences announced the peer reviewed publication of their licensed cannabinoid-derived drug program for…
On Nov. 5, 2018, Pascal Biosciences announced the peer reviewed publication of their licensed cannabinoid-derived drug program for…
On Nov. 1, 2018, City of Hope, and its affiliate, Translational Genomics Research Institute (TGen), announced a letter…
On Oct. 30, 2018, Pascal Biosciences announced the Company had entered into an exclusive license agreement with the…
On Oct. 22, 2018, the Siteman Cancer Center announced a second proton therapy system that would incorporate pencil-beam…
On Nov. 9, 2918, the U.S. Centers for Disease Control and Prevention (CDC) reported an estimated 47.4 million…
On Oct. 5, 2018, the FDA announced it had approved a supplemental application for Gardasil 9 (Human Papillomavirus…
On Sept. 27, 2018, St.ᅠJude Children’s Hospital and the World Health Organization announced a five-year collaboration to transform…
On Sept. 25, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced the formation of the…
On Sept. 7, 2018, Oregon Health & Science University (OHSU) announced the official completion of the Knight Cancer…
On Aug. 29, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it would invest up…
On Aug. 2, 2018, Emory University and GeoVax Labs partnered to develop a vaccine for HPV, with an…
On Jul. 17, 2018, the Keck School of Medicine of USC announced that it was leading a $26.5…
On Jun. 5, 2018, a new flagship cancer center was established as the Fred & Pamela Buffett Cancer…
On May 21, 2018, the National Cancer Institute awarded Keck School of Medicine of USC and USC Norris…
On May 18, 2018, The Barbara Ann Karmanos Cancer Institute announced it will expand its Lawrence and Idell…
On May 18, 2018, the Boykin family pledged $10 million to support Cleveland Clinic’s Taussig Cancer Institute. Paula…
On May 14, 2018, University of California, Los Angeles (UCLA) researchers characterized the mechanism of the mammalian EAK-7…
On Apr. 30, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced a Seed Award for…
On Apr. 5, 2018, researchers funded by the National Institutes of Health (NIH) announced they had completed a…
On Feb. 21, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded 49 new academic research…
In 2018, the University of Michigan Cancer Center was renamed the Rogel Cancer Center in recognition of a…
In 2018, the Lombardi Comprehensive Cancer Center became the 16th National Cancer Institute-designated Comprehensive Cancer Center funded with…
On Dec. 13, 2017, longtime Omaha art teacher and businessman Gerald “Jerry” Pabst donated $3 million through an…
On Nov. 16, 2017, Columbia University and NewYork-Presbyterian announced that Florence Irving and her late husband, Herbert Irving,…
On Oct. 18, 2017, the Siteman Cancer Center became one of the first cancer centers nationwide to offer…
On Oct. 12, 2017, the NIH and 11 leading biopharmaceutical companies launched the Partnership for Accelerating Cancer Therapies…
On Oct. 2, 2017, Emory University was selected by the National Cancer Institute (NCI) for participation in an…
On Aug. 30, 2017, the U.S. Food and Drug Administration (FDA) approved Kymriah (tisagenlecleucel) for certain pediatric and…
On Aug. 16, 2017, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded 60 new academic research,…
On Aug. 15, 2017, the National Institutes of Health’s (NIH) Gabriella Miller Kids First Pediatric Research Program awarded…